These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 28019089)
1. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer. Corbo C; Cevenini A; Salvatore F Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089 [TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer. Ma H; Chen G; Guo M Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366 [TBL] [Abstract][Full Text] [Related]
3. Proteomics for early detection of colorectal cancer: recent updates. Alnabulsi A; Murray GI Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727 [TBL] [Abstract][Full Text] [Related]
4. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives. Lee PY; Chin SF; Low TY; Jamal R J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962 [TBL] [Abstract][Full Text] [Related]
5. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer. Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358 [TBL] [Abstract][Full Text] [Related]
6. Personalized treatment for patients with colorectal cancer: role of biomarkers. Duffy MJ Biomark Med; 2015; 9(4):337-47. PubMed ID: 25808438 [TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of minute amount of colonic biopsies by enteroscopy sampling. Liu X; Xu Y; Meng Q; Zheng Q; Wu J; Wang C; Jia W; Figeys D; Chang Y; Zhou H Biochem Biophys Res Commun; 2016 Aug; 476(4):286-292. PubMed ID: 27230957 [TBL] [Abstract][Full Text] [Related]
8. Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective. Hoseini SH; Enayati P; Nazari M; Babakhanzadeh E; Rastgoo M; Sohrabi NB J Gastrointest Cancer; 2024 Jun; 55(2):497-510. PubMed ID: 38168859 [TBL] [Abstract][Full Text] [Related]
9. New trends in molecular and cellular biomarker discovery for colorectal cancer. Aghagolzadeh P; Radpour R World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083 [TBL] [Abstract][Full Text] [Related]
10. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615 [TBL] [Abstract][Full Text] [Related]
11. Biomarker Identification through Proteomics in Colorectal Cancer. Martín-García D; García-Aranda M; Redondo M Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396959 [TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives. Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776 [TBL] [Abstract][Full Text] [Related]
13. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach. Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854 [TBL] [Abstract][Full Text] [Related]
14. Mining the fecal proteome: from biomarkers to personalised medicine. Jin P; Wang K; Huang C; Nice EC Expert Rev Proteomics; 2017 May; 14(5):445-459. PubMed ID: 28361558 [TBL] [Abstract][Full Text] [Related]
15. Chasing the personalized medicine dream through biomarker validation in colorectal cancer. Patil H; Saxena SG; Barrow CJ; Kanwar JR; Kapat A; Kanwar RK Drug Discov Today; 2017 Jan; 22(1):111-119. PubMed ID: 27693431 [TBL] [Abstract][Full Text] [Related]
16. Proteomics for discovery of candidate colorectal cancer biomarkers. Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574 [TBL] [Abstract][Full Text] [Related]
17. Proteomic Approaches for Biomarker Panels in Cancer. Tanase C; Albulescu R; Neagu M J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430 [TBL] [Abstract][Full Text] [Related]
18. Novel Diagnostic Biomarkers in Colorectal Cancer. Zygulska AL; Pierzchalski P Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055034 [TBL] [Abstract][Full Text] [Related]
19. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers. Ang CS; Baker MS; Nice EC Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566 [TBL] [Abstract][Full Text] [Related]
20. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue. Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]